Evidence map›Paper›PMID 35744591›Full record

ArticleMicromachines2022

Rational Design of Microfluidic Glaucoma Stent.

Thomas Graf, Gitanas Kancerevycius, Linas Jonušauskas, Patric Eberle

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thomas GrafInstitute of Electrical Engineering, Lucerne University of Applied Sciences, CH-6048 Horw, Switzerland.
Gitanas KancerevyciusValsigna GmbH, Via Luganetto 4, CH-6962 Lugano-Viganello, Switzerland.
Linas JonušauskasValsigna GmbH, Via Luganetto 4, CH-6962 Lugano-Viganello, Switzerland.
Patric EberleInstitute of Electrical Engineering, Lucerne University of Applied Sciences, CH-6048 Horw, Switzerland.ORCID 0000-0002-1927-6096
Lucerne University of Applied Sciences and Arts · CH

Funding

Innosuisse - Swiss Innovation Agency 53982.1 INNO-LS
6 · The paper itself

Abstract

Glaucoma is a common, irreparable eye disease associated with high intraocular pressure. One treatment option is implantation of a stent to lower the intraocular pressure. A systematic approach to develop a microchannel stent meshwork that drains aqueous humor from the anterior chamber of the eye into the subconjunctival space is presented. The stent has a large number of outlets within its mesh structure that open into the subconjunctiva. The development approach includes a flow resistance model of the stent. Local adaption of the stent's tubular dimensions allows for adjustment of the flow resistance. In this way, an evenly distributed outflow into the subconjunctiva is achieved. We anticipate that microblebs will form at the stent outlets. Their size is crucial for drainage and control of intraocular pressure. An analytical model for bleb drainage is developed based on the porous properties of the subconjunctival tissue. Both models-the stent flow resistance model and the bleb drainage model-are verified by numerical simulation. The models and numerical simulation are used to predict intraocular pressure after surgery. They allow for a systematic and personalized design of microchannel stents. Stents designed in this way can stabilize the intraocular pressure between an upper and lower limit.

Indexed as

bleb drainageflow resistance modelglaucomaIOP stabilizationmicrofluidic stent

Identifiers

PMID35744591
PMCPMC9229318
OpenAlexW4283214504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.